Blog
Featured
Regulatory Uncertainty Persists Around Medical Software
On January 7th the FDA announced the launch of a new streamlined regulatory framework for digital health devices. Specifically, the framework is initially focused on products which the FDA classifies as “software as a medical device” or SaMD, and the framework may eventually be expanded to all medical device software.
Our BrightInsight Brand Launch
The State of Digital Health VC Funding
News
Events
JP Morgan Healthcare Conference
Join us at the 37th annual JP Morgan Healthcare Conference at our digital health panel on real-world data.
Future Health Basel
Connect onsite with our European business lead, Marcelo Duhalde, to discuss digital health innovation.